In places like Australia, where metropolitan areas are separated by an entire continent, donor hearts used to go unused simply because transplant teams couldn't get the organ to a recipient in time.

A new medical technology expected to be on the market in 2027 is poised to help patients in middle America have greater access to heart transplants. Xvivo Perfusion, a leader in organ transplant ...

The US Food and Drug Administration (FDA) has conditionally approved TransMedics Group’s investigational device exemption (IDE) to commence the next-generation OCS ENHANCE Heart study. Part A of the ...

Using the Organ Care System (OCS) Heart platform to perfuse, optimize, and assess donor hearts has excellent outcomes, including 87% of extended criteria donor (ECD) hearts being successfully ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. TransMedics Group (NasdaqGM:TMDX) received full FDA approval for its ...

The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...

Please provide your email address to receive an email when new articles are posted on . Most respondents reported they would undergo a donation procedure that maximized use of their organs. Many ...

Perfusion describes when fluids such as blood and lymph pass through tissue. A perfusionist is a professional who operates machinery when this process requires assistance, such as during heart surgery ...

Here 10 notable cardiology firsts since March 17, as reported by Becker’s: 1. A team at Durham, N.C.-based Duke Health successfully developed and performed the world’s first on-table heart reanimation ...